Zymeworks (ZYME) Sof foyda bo'yicha sotuv rentabelligi

Zymeworks Inc. (ZYME) tovar belgisi

Zymeworks Inc. ko'p milliard dollarlik hamkorlik shartnomalaridan foydalangan holda o'zining ko'p spesifik antitanalar platformasini kengaytirmoqda. Noyob proteinlar ishlab chiqilishi o'ta muhim maqsadli terapiyalarni yaratish orqali moliyaviy barqarorlikni ta'minlaydi. Kompaniya immuno-onkologiya bozorini qamrab olgan holda, onkologiya markazlariga innovatsion dori vositalarini yetkazib beradi. Sof foyda marjasi biznes samaradorligini namoyish etadi va 16.30 belgisi ushbu ko'rsatkichni qayd etmoqda.

ZYME: Zymeworks Biopharmaceuticals Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Zymeworks Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:zymeworks.com - ZYME
Zymeworks Corp yetakchi tovari

Professional menejerlar barcha operatsion va soliq xarajatlarini chegirib tashlagandan so'ng, tushumni sof foydaga aylantirish samaradorligini baholash uchun fundamental filtrlardan foydalanadilar. Ushbu ko'rsatkich erkin mablag'larning ulushini aks ettiradi, Zymeworks Inc. (ZYME) uchun esa bu ko'rsatkich Zanidatamab dan keladigan royalti oqimiga va ADC terapiyasining muvaffaqiyatiga kritik darajada bog'liq bo'lib, sotuvlarning yakuniy sof daromadliligini belgilaydi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi TNGX (Tango Pharma)|Kompaniyaning sof rentabelligi IOVA|Sotuvning sof marjinal rentabelligi IMTX (Immatics)|Sof foyda normasi XNCR|compasstherapeutics.com - Sotuvning sof marjinal rentabelligi|Sof marja Replimune Inc.|Lyell Immunopharma (LYEL) - Sof marja|Innate Pharma S.A. - Sof foyda normasi|PYXS (Pyxis) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi cgen.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)